IPC logo

IPC The Hospitalist Company Acquires Connecticut Geriatric Practice

| Source: IPC Healthcare, Inc.

NORTH HOLLYWOOD, Calif., Aug. 7, 2014 (GLOBE NEWSWIRE) -- IPC The Hospitalist Company, Inc. (Nasdaq:IPCM), a leading national hospital medicine and post-acute physician group practice company, today announced that it has acquired GeriCare, LLC. GeriCare is a post-acute medical group practice with operations throughout the state of Connecticut.

R. Jeffrey Taylor, president and COO of IPC, stated, "GeriCare has a well-established presence in Connecticut and a reputation of promoting health to the geriatric and sub-acute populations with dedication, a passion for service to seniors, and a commitment to partner with the staff at each of the client facilities they serve. We are excited to have them join our IPC family, while expanding our existing post-acute presence in the Connecticut market."

GeriCare's co-founder and chief clinical officer Joseph Brenes, M.D., will continue to provide clinical leadership to the practice under IPC. Dr. Brenes commented, "The ability for us to leverage the clinical and operational expertise of IPC, as well as our shared commitment to improving the health of sub-acute patients and long-term care residents, align perfectly for providing seniors with the best possible care."

GeriCare's patient encounters are estimated at approximately 42,500 on an annualized basis.

About IPC The Hospitalist Company, Inc.

IPC The Hospitalist Company, Inc. (Nasdaq:IPCM) is a leading national hospital medicine and post-acute physician group practice company. IPC's physicians and affiliated providers practice in over 400 hospitals and 1,200 post-acute care facilities. The Company offers its 1,700 employed clinicians comprehensive training, information technology, and management support systems to improve the quality and reduce the cost of patient care in the facilities it serves. For more information, visit the IPC website at www.ipcm.com.

Media Contact:
Scott Public Relations
Elaine Murphy

Investor Contact:
Evan Pondel